Journal article · Research (general)← The news desk

✦ The Dispatch

Automated dose-gradient curve and dose-volume histogram analysis platform: development, validation, and clinical decision support with TG-119 datasets

A dispatch from PubMed — filed

Highly conformal radiotherapy techniques, such as stereotactic radiosurgery and stereotactic ablative radiotherapy, require steep dose fall-off to spare organs at risk (OARs). The dose-volume histogram (DVH) provides limited spatial information, whereas the dose gradient curve (DGC) offers quantitative assessment of dose fall-off but has seen limited clinical use due to time-consuming manual processing....

Clinical Takeaway

No actionable change for audiologists; this article concerns a radiotherapy planning quality-assurance tool with no direct relevance to hearing health or audiology practice.

Why It Matters

Tangentially relevant to audiology only in the context of ototoxicity (medication- or radiation-related hearing damage) monitoring in head-and-neck cancer patients; the tool itself is a radiation oncology decision-support system.

Key Points
  1. 01An automated platform was developed to analyse dose-gradient curves and dose-volume histograms in radiotherapy.
  2. 02The tool was validated against TG-119 datasets, a radiotherapy quality-assurance benchmark.
  3. 03Clinical decision support focus is radiation oncology, not audiology.
  4. 04Minimal direct relevance to hearing health or audiological practice.
  5. 05Published in Frontiers in Oncology.
Claims & Evidence

The automated platform was validated using TG-119 radiotherapy datasets.

studysupported
Research metadata
PMID
42245709
DOI
10.3389/fonc.2026.1826856.
Related stories